Suppr超能文献

人结肠癌细胞系LS513中外排转运蛋白ABCB1、ABCC2和ABCG2的表达与活性

Expression and activity of the efflux transporters ABCB1, ABCC2 and ABCG2 in the human colorectal carcinoma cell line LS513.

作者信息

Salphati Laurent, Plise Emile G, Li Guangmin

机构信息

Drug Metabolism and Pharmacokinetics Department, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States.

出版信息

Eur J Pharm Sci. 2009 Jun 28;37(3-4):463-8. doi: 10.1016/j.ejps.2009.04.001. Epub 2009 Apr 9.

Abstract

The human colorectal carcinoma cell line LS513 exhibits epithelial morphology, adherent properties and can grow subcutaneously to form tumors in nude mice. Thus, it is a potential model for mouse xenograft efficacy studies. The present study characterized the expression and activity of P-gp, BCRP and MRP2 in LS513 cells. We investigated the expression of these ATP-binding cassette transporters by Western blot and their activity was also examined using cell culture inserts, where the LS513 cells were grown to confluence for 9 days. The transport of model substrates of P-gp (amprenavir, ritonavir and topotecan), BCRP (topotecan) and MRP2 (SN-38) was studied in the apical to basolateral (A-B) and basolateral to apical (B-A) directions. P-gp, BCRP and MRP2 could be detected by western blot. The LS513 cells exhibited markedly higher transport in the B-A direction than in the A-B direction for the probe substrates tested, with efflux ratios (ERs; B-A/A-B) of 10, 21, 40 and 50 for amprenavir, ritonavir, topotecan and SN38, respectively. The ER could be significantly reduced with the addition of inhibitors of P-gp (GF120918), BCRP (FTC), and MRP2 (MK571), confirming the activity of these transporters in the LS513 cells.

摘要

人结肠癌细胞系LS513呈现上皮形态和贴壁特性,可在裸鼠皮下生长形成肿瘤。因此,它是小鼠异种移植疗效研究的潜在模型。本研究对LS513细胞中P-糖蛋白(P-gp)、乳腺癌耐药蛋白(BCRP)和多药耐药相关蛋白2(MRP2)的表达及活性进行了表征。我们通过蛋白质印迹法研究了这些ATP结合盒转运蛋白的表达,并使用细胞培养插入物检测了它们的活性,其中LS513细胞生长至汇合状态9天。研究了P-gp(安普那韦、利托那韦和拓扑替康)、BCRP(拓扑替康)和MRP2(SN-38)模型底物在顶侧到基底侧(A-B)和基底侧到顶侧(B-A)方向的转运。通过蛋白质印迹法可检测到P-gp、BCRP和MRP2。对于所测试的探针底物,LS513细胞在B-A方向的转运明显高于A-B方向,安普那韦、利托那韦、拓扑替康和SN38的外排率(ERs;B-A/A-B)分别为10、21、40和50。添加P-gp抑制剂(GF120918)、BCRP抑制剂(FTC)和MRP2抑制剂(MK571)后,ER可显著降低,证实了这些转运蛋白在LS513细胞中的活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验